Medicine
Scandonest 3% Plain 51 mg/1.7 mL injection
Scandonest 3% Plain 51 mg/1.7 mL injection is a prescription medicine containing Mepivacaine for subcutaneous use, marketed by Septodont, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not permit to freeze. Solution should be stored at controlled room…
Key facts
- Active ingredient (INN)
- Mepivacaine
- Brand
- Scandonest 3% Plain
- Strength
- 51 mg/1.7 mL
- Dosage form
- Injection
- Route
- Subcutaneous
- Packs
- 5 blister pack of 1.7 mL
- Marketing authorisation holder
- Septodont
- Manufacturer
- Septodont
- Origin register
- US FDA, United States
- Storage
- Do not permit to freeze. Solution should be stored at controlled room temperature, below 25°C (77°F). Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N01BB03 Mepivacaine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 22 December 2017
- Identifiers
- RxCUI 1012762, 1305263DailyMed set ID af6ff5f6-7221-421b-9b7c-8fcee4a47772NDC 0362-1098Application ANDA088387
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 5 blister pack in 1 carton / 10 cartridge in 1 blister pack / 1.7 mL in 1 cartridge | 0362-1098-90 | Septodont | 22 December 2017 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 6 January 1960 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Mepivacaine 51 mg/1.7 mL injection.
Other strengths and forms of Mepivacaine
Clinical summary
Mepivacaine is an amide local anesthetic indicated for production of local anesthesia for dental procedures by infiltration or nerve block in adults and pediatric patients. It is available as injection for submucosal, infiltration and epidural use. MedsAcross supplies Mepivacaine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MepivacaineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Scandonest 3% Plain prescribing information (Septodont) · U.S. National Library of Medicine, DailyMed
Need Scandonest 3% Plain 51 mg/1.7 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.